Cost-effectiveness of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant versus long-acting stimulant monotherapy for the treatment of attention-deficit/hyperactivity disorder in Canada
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1251
https://www.valueinhealthjournal.com/article/S1098-3015(14)01302-3/fulltext
Title :
Cost-effectiveness of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant versus long-acting stimulant monotherapy for the treatment of attention-deficit/hyperactivity disorder in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01302-3&doi=10.1016/j.jval.2014.03.1251
First page :
A214
Section Title :
Mental Health
Open access? :
No
Section Order :
716